Key Insights

Highlights

Treatment Research

3 treatments under study, led by Rouxeny Gastric Bypass Rygb

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Research Network

Common Treatments

  • Rouxeny Gastric Bypass Rygb1
  • Gastric Peroral Endoscopic Myotomy Gpoem1
  • Endoscopic Pneumatic Balloon Dilation1

Active Sponsors

  • Johns Hopkins University1

Top Investigators

Activity Timeline